views
The Eisenmenger Syndrome Treatment Market is predicted to expand at a CAGR during the forecast period. The rise in cardiovascular patients and high blood pressure cases around the world, as well as expanding governmental and private sector R&D activities in the pharmaceutical industry for treating Eisenmenger syndrome, are the main factors anticipated to fuel Eisenmenger Syndrome Treatment Market expansion during the forecast period.
Based on drug type, diagnosis, and distribution channel, the Global Eisenmenger Syndrome Treatment Market has been divided into submarkets. The market is divided into endothelin receptor antagonists, blood thinners, and other drugs based on the kind of medicine. The market is divided into sub-segments based on diagnosis, including cardiac catheterization, computerised tomography (CT) scan, echocardiography, chest x-ray, and electrocardiogram (ECG). The market is split into hospital pharmacies, internet pharmacies, and retail pharmacies based on the distribution route.